Digital Politics With Karen Jagoda

Dr. Joe Tucker, CEO of Enveric Biosciences, shines a light on the challenges of those working with psychedelic therapies to inform legislators about the need for regulation to gain acceptance for the use of these molecules for medicinal purposes. In this era of increasing mental health awareness and neurodegenerative diseases, research on the unique characteristics of hallucinogenic and non-hallucinogenic drugs shows the potential to meet unmet medical needs effectively. We talk about: The greatest need for psilocybin-based therapies How drug developers are making psychedelic therapies that are safer and more accessible Why these therapies need to be regulated What elected officials can do to encourage more research #Enveric #PsilocybinBasedTherapies #Psilocybin #PsychedelicTherapies #Psychedelics  Enveric.com